CVRX — CVRx Inc
NASDAQ · Healthcare · Medical Devices
$3.08
+$0.04 (+1.15%)
CVRx Inc (CVRX) is a medical devices company listed on NASDAQ. It is led by Kevin Hykes, based in 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445, with about 223 employees. CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Latest reported CVRX revenue for 2025-09-30 was $14.7M. Net income was -$41.4M. Revenue was up 8.1% from 2025-06-30 to 2025-09-30. CVRX currently screens at market cap $142.8M.
Use this CVRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CVRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CVRX SEC filings page. Lician reads the product cache first so this HTML stays unique to CVRx Inc even when a live quote feed is slow.
About CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRX Key Statistics
Market Cap
$142.76M
Volume
875,467
Previous Close
$3.37
Day Range
$3.15 – $3.40
EPS
-$2.65
Revenue
$51.29M
Net Income
-$59.97M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+30.5%
Profit Margin
-116.9%
Employees
223
CVRX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $51.29M | $39.30M | $22.47M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$59.97M | -$41.20M | -$41.43M |
| EPS (Diluted) | -$2.65 | -$1.99 | -$2.02 |
Total Assets
$133.41M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$105.93M
Operating Cash Flow
-$39.14M
Free Cash Flow
$0.00
CVRx Inc Company Information
- President, CEO & Director
- Kevin Hykes
- Headquarters
- 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445
- Website
- www.cvrx.com
- Phone
- 763 416 2840
- IPO / Founded
- 2021-06-30
- Sector
- Healthcare
- Industry
- Medical Devices